Impact - Protein Expression Facility - University of Queensland

With thousands of expression constructs and hundreds of proteins, PEF has enabled research groups across 21 Australian universities, together with national and international users from industry and government sectors to accelerate their research.

From simple biomolecules to complex multi-protein assemblies, PEF has an outstanding reputation for delivering exceptional service and high quality recombinant proteins.

Impact stories

PATH and PEF create custom proteins for malaria diagnostics

Collaboration between PATH and UQ's Protein Expression Facility supports custom proteins for malaria diagnostics
Queensland-made antibody test for COVID-19 detection

Queensland-made proteins and sophisticated antibody test for COVID-19 detection
Rapid response to combat COVID-19

Australian research partnership provides rapid and reliable diagnostic testing for COVID-19
Diagnostic tool for Zika virus

Queensland Health - PEF collaboration to develop a faster and safer diagnostic tool for Zika virus
Innovative recombinant snake venom protein set to save lives

Inspired by the venom of deadly snakes, RAPClot technology aims to optimise patient outcomes

PEF: Building Australia's bio-manufacturing capability

The COVID-19 pandemic has highlighted how important it is for Australia to foster a healthy biotechnology industry.
National investment to produce revolutionary mRNA therapies at UQ

A pilot facility at The University of Queensland could be producing mRNA vaccines and cancer therapies for research and development within months after receiving backing from the Australian Government.
PATH and The University of Queensland create custom proteins for malaria diagnostics

PATH and The University of Queensland’s Protein Expression Facility have collaborated to develop and bring to market custom proteins to support the development and evaluation of point-of-care diagnostics for malaria.
UQ facilities helped develop home COVID-19 test

State-of-the-art University of Queensland research facilities have been critical to the development of a 20-minute, smartphone-linked, home COVID-19 diagnostic test now available in the US.
PEF wins Deputy Vice-Chancellor (Research and Innovation)'s Impact Award 2020

The Impact Award recognises a team that has had a positive impact throughout the year both within the Research and Innovation Portfolio, and more broadly.
UQ Research and Innovation Expertise Staff Awards

PEF wins the inaugural Deputy Vice Chancellor (Research) award for team excellence 2018.
Researchers using donut-shaped molecules to make a new bird flu vaccine

Professor Linda Lua, Director of the Protein Expression Facility housed at AIBN, is developing a new vaccine candidate for avian influenza.
Next-gen polio vaccine tackles wild virus emergency

Vaccine technology being developed at The University of Queensland could hold the key to completely eradicating polio by removing live virus from the vaccine production process.
Zika virus boffins go out on a limb

UQ’s Protein Expression Facility director, Associate Professor Linda Lua, said future research may also show that Zika virus synthetic proteins are an effective way to induce an immune response, paving the way for tailored treatments.
UQ Award for Excellence in Service

Awarded to those who have made outstanding and significant contribution to delivering excellence in service to students, staff or the wider community.